BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 10364643)

  • 1. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE and modulation of Alzheimer's and frontotemporal dementia.
    Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB
    Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of brain activation in people at risk for Alzheimer's disease.
    Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
    N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of APOE in mild cognitive impairment.
    Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
    Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia, quantitative neuroimaging, and apolipoprotein E genotype.
    Bigler ED; Lowry CM; Anderson CV; Johnson SC; Terry J; Steed M
    AJNR Am J Neuroradiol; 2000; 21(10):1857-68. PubMed ID: 11110538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease.
    Morgen K; Ramirez A; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S269-76. PubMed ID: 24613704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.